These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16452467)
1. Relationship between UDP-galactose 4'-epimerase activity and galactose sensitivity in yeast. Wasilenko J; Fridovich-Keil JL J Biol Chem; 2006 Mar; 281(13):8443-9. PubMed ID: 16452467 [TBL] [Abstract][Full Text] [Related]
2. Distinct roles of galactose-1P in galactose-mediated growth arrest of yeast deficient in galactose-1P uridylyltransferase (GALT) and UDP-galactose 4'-epimerase (GALE). Mumma JO; Chhay JS; Ross KL; Eaton JS; Newell-Litwa KA; Fridovich-Keil JL Mol Genet Metab; 2008 Feb; 93(2):160-71. PubMed ID: 17981065 [TBL] [Abstract][Full Text] [Related]
3. Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast. Ross KL; Davis CN; Fridovich-Keil JL Mol Genet Metab; 2004; 83(1-2):103-16. PubMed ID: 15464425 [TBL] [Abstract][Full Text] [Related]
4. The molecular basis of galactosemia - Past, present and future. Timson DJ Gene; 2016 Sep; 589(2):133-41. PubMed ID: 26143117 [TBL] [Abstract][Full Text] [Related]
10. Genetics of galactose metabolism of Erwinia amylovora and its influence on polysaccharide synthesis and virulence of the fire blight pathogen. Metzger M; Bellemann P; Bugert P; Geider K J Bacteriol; 1994 Jan; 176(2):450-9. PubMed ID: 7507102 [TBL] [Abstract][Full Text] [Related]
12. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient. Schulpis KH; Thodi G; Chatzidaki M; Iakovou K; Molou E; Dotsikas Y; Loukas YL J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1119-1120. PubMed ID: 28902631 [No Abstract] [Full Text] [Related]
13. UDP-galactose 4' epimerase (GALE) is essential for development of Drosophila melanogaster. Sanders RD; Sefton JM; Moberg KH; Fridovich-Keil JL Dis Model Mech; 2010; 3(9-10):628-38. PubMed ID: 20519568 [TBL] [Abstract][Full Text] [Related]
14. The occurrence of the Leloir pathway in non-pathogenic mycobacteria. Szumiło T Acta Microbiol Pol; 1981; 30(4):327-33. PubMed ID: 6179392 [TBL] [Abstract][Full Text] [Related]
15. Galactose and cataract. Stambolian D Surv Ophthalmol; 1988; 32(5):333-49. PubMed ID: 3043741 [TBL] [Abstract][Full Text] [Related]
17. Toxicity of 2-deoxygalactose to Saccharomyces cerevisiae cells constitutively synthesizing galactose-metabolizing enzymes. Platt T Mol Cell Biol; 1984 May; 4(5):994-6. PubMed ID: 6328283 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of disorders of human galactose metabolism: past, present, and future. Novelli G; Reichardt JK Mol Genet Metab; 2000; 71(1-2):62-5. PubMed ID: 11001796 [TBL] [Abstract][Full Text] [Related]
19. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase. Quimby BB; Alano A; Almashanu S; DeSandro AM; Cowan TM; Fridovich-Keil JL Am J Hum Genet; 1997 Sep; 61(3):590-8. PubMed ID: 9326324 [TBL] [Abstract][Full Text] [Related]
20. D-galactose catabolism in Penicillium chrysogenum: Expression analysis of the structural genes of the Leloir pathway. Jónás Á; Fekete E; Németh Z; Flipphi M; Karaffa L Acta Biol Hung; 2016 Sep; 67(3):318-32. PubMed ID: 27630054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]